Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten
in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM Study.
Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, Komiyama N, Sakata Y,
Maekawa Y, Minami Y, Ogimoto A, Takaya T, Yasuda S, Amiya E, Furukawa Y, Watanabe T,
Hiraya D, Miyagoshi H, Kinoshita G, Reedy A, Hegde SM, Florea V, Izumi C.
Circ J. 2024 Nov 7. doi: 10.1253/circj.CJ-24-0501. Online ahead of print.
論文は
こちらから。